CHC Radio

Omicron Could Be as Deadly as Delta, Boosters’ Short Protection &‘Dangerous’ Oral COVID Pill from Merck: A Talk With William Haseltine

This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.

Kimberly Pena

Share
Published by
Kimberly Pena

Recent Posts

Congress Races to Find Obamacare Subsidy Solution: Reporters Examine the Efforts

Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…

2 days ago

Flu Cases Rising: “It’s Not Good,” Says Former CDC Dir. Dr. Tom Frieden

Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…

2 days ago

Can You Have a ‘Healthy’ Thanksgiving? How the Food Industry Conspires Against Us

Leading nutritionist Marion Nestle, Ph.D., has a sobering message as we get ready for Thanksgiving:…

3 weeks ago

How Dr. Sanjeev Arora Helped Improve Care for 200 Million Patients

People around the world are living longer and healthier lives because of an innovative idea…

3 weeks ago

“Cash for Moms and Babies”: How it Works & Why  

Originally broadcast November 13, 2025 What if health care for moms and babies came with…

1 month ago

Intimate Partner Violence: Health Care Providers’ Role

Originally broadcast November 6, 2025 Intimate partner violence affects more women in the United States…

1 month ago